---
schema_version: "secwatch.filing_event.v1"
accession: "0001606498-25-000087"
form_type: "8-K"
ticker: "AVNS"
cik: "0001606498"
company_name: "AVANOS MEDICAL, INC."
filed_at: "2025-05-06T23:59:59+00:00"
generated_at: "2026-05-22T12:02:32.555148+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Avanos Q1 EPS $0.14, adjusted EPS $0.26; cuts 2025 adj. EPS view to $0.75-$0.95 on tariffs

## Summary
- Net sales $167.5M (+0.8% YoY); organic net sales up 2.8%.
- Net income $6.6M ($0.14 diluted EPS) vs $0.5M ($0.01) a year ago; adjusted net income $12.0M ($0.26 adjusted EPS).
- SNS segment net sales $101.1M with 8.7% volume growth driven by enteral feeding and neonate solutions.
- PM&R segment net sales $56.2M; RFA product sales grew 8.2% from ESENTEC/TRIDENT momentum.
- 2025 revenue guidance reaffirmed at $665-$685M; adjusted EPS guidance lowered to $0.75-$0.95 due to tariff impacts.

## SEC filing metadata
- accession: 0001606498-25-000087
- form_type: 8-K
- ticker: AVNS
- cik: 0001606498
- company_name: AVANOS MEDICAL, INC.
- filed_at: 2025-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649825000087/0001606498-25-000087-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606498/000160649825000087/avns-20250506.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606498-25-000087
- JSON: https://secwatch.observer/filing/0001606498-25-000087.json
- Plain text: https://secwatch.observer/filing/0001606498-25-000087.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.